256 related articles for article (PubMed ID: 29777702)
1. microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.
He L; Meng D; Zhang SH; Zhang Y; Deng Z; Kong LB
Biochem Biophys Res Commun; 2018 Jul; 501(4):1060-1067. PubMed ID: 29777702
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
3. BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhang P; Dong Z; Cai J; Zhang C; Shen Z; Ke A; Gao D; Fan J; Shi G
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):36-44. PubMed ID: 25816404
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p.
Peng Y; Leng W; Duan S; Hong M
Biomed Pharmacother; 2019 Aug; 116():109027. PubMed ID: 31174090
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
[TBL] [Abstract][Full Text] [Related]
7. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
Tan W; Lim SG; Tan TM
World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
10. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
11. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
Biomed Pharmacother; 2016 Apr; 79():315-20. PubMed ID: 27044843
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
14. Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.
Pu J; Wu X; Wu Y; Shao Z; Luo C; Tang Q; Wang J; Wei H; Lu Y
Aging (Albany NY); 2021 Mar; 13(8):12207-12223. PubMed ID: 33952719
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.
Hu S; Tao R; Wang S; Wang C; Zhao X; Zhao H; Li L; Zhu S; He Y; Jiang X; Gao Y
Tumour Biol; 2015 Jul; 36(7):5467-72. PubMed ID: 25687183
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.
Wang P; Zhuang C; Huang D; Xu K
Oncol Rep; 2016 Jul; 36(1):247-52. PubMed ID: 27222047
[TBL] [Abstract][Full Text] [Related]
17. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
Zhao J; Xu T; Wang F; Cai W; Chen L
Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
20. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
Xia W; Ni J; Zhuang J; Qian L; Wang P; Wang J
Int J Biochem Cell Biol; 2016 Feb; 71():1-11. PubMed ID: 26646106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
